SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

SCCM Pod-400 Are AKI Biomarkers Ready for Clinical Use?

visual bubble
visual bubble

Kyle B. Enfield, MD, FCCM, and Azra Bihorac, MD, MS, FCCM, discuss best practices and complexities of implementing biomarkers for kidney stress and acute kidney injury (AKI) and what the future holds for AKI biomarker literature. Dr. Bihorac was a presenter on this topic at the Society's 48th Critical Care Congress. Dr. Bihorac is the R. Glenn Davis professor of medicine, surgery, and anesthesiology in the division of nephrology, hypertension, and renal transplant within the department of medicine at the University of Florida in Gainesville, Florida, USA. This podcast is part 4 of a series sponsored by Baxter Healthcare Corporation.

*If you are unable to play the podcast please click here to download the file.

Category: Other



Knowledge Area: Renal